Sökning: "patent settlement"

Visar resultat 1 - 5 av 15 uppsatser innehållade orden patent settlement.

1. 1. Ingen regel utan undantag? Om upphovsrättsligt skyddat material som bevisning i dispositiva tvistemål

   Kandidat-uppsats, Lunds universitet/Juridiska institutionen; Lunds universitet/Juridiska fakulteten

   Författare :Anna Perklev; [2022]
   Nyckelord :private law; EU-law; intellectual property law; copyright law; procedual law; Law and Political Science;

   Sammanfattning : Under copyright law, the originator has the exclusive right to his or her work, which includes reproduction as well as the right of communication to the public and the right of making it available to the public. The exclusive right means that others may not use the work in a way that infringes the exclusive right without the rightholder’s consent. LÄS MER

3. 2. Reverse Payment Patent Settlements as Restrictions by Object under Article 101(1) TFEU

   Uppsats för yrkesexamina på avancerad nivå, Lunds universitet/Juridiska institutionen; Lunds universitet/Juridiska fakulteten

   Författare :Melina Idolor; [2022]
   Nyckelord :Pay for delay; Reverse-Payment Patent Settlements; Reverse Payment Patent Settlements; patent settlements; restriction by object; competition law; EU competition law; Pharmaceutical Industry; pay-for-delay; Law and Political Science;

   Sammanfattning : This thesis examines the CJEU’s case law on value transfers between originator and generic undertakings, in the context of patent settlements, to ascertain the criteria for determining when such a practice amounts to a restriction of competition by object. The thesis finds that the CJ’s rulings in Generics and Lundbeck clarifies the treatment of more straightforward RPPSs and follows established case law on restrictions by object. LÄS MER

4. 3. Patentförlikningar inom läkemedelssektorn och förbudet mot konkurrensbegränsande avtal – en jämförelse mellan EU-rätt och amerikansk rätt

   Kandidat-uppsats, Lunds universitet/Institutionen för handelsrätt

   Författare :Hanna Brännström; [2020]
   Nyckelord :patentförlikningar; konkurrensrätt; patenträtt; förbjudna konkurrensbegränsande avtal; artikel 101 FEUF; Sherman Act 15 U.S.C. § 1; läkemedelssektorn; patent settlements; competition law; antitrust law; patent law; originator company; generic company; Law and Political Science;

   Sammanfattning : Läkemedelsmarknaden är uppbyggd runt företag, så kallade originalföretag, som utvecklar nya läkemedel och patenterar dessa. Patent är viktigt eftersom det ger originalföretagen en tidsbegränsad monopolistisk marknadsställning. LÄS MER

5. 4. Pay-for-delay i läkemedelssektorn ur ett konkurrensrättsligt perspektiv

   Kandidat-uppsats, Lunds universitet/Juridiska institutionen; Lunds universitet/Juridiska fakulteten

   Författare :Rebecca Edvardsson; [2020]
   Nyckelord :Konkurrensrätt; Patenträtt; Immaterialrätt; Rättsvetenskap; Pay-for-delay; Läkemedelspatent; Patent; Patenttvist; Patentskydd; Law and Political Science;

   Sammanfattning : The pharmaceutical market in the EU is very complex because of its many actors with different economic and political interests as well as its legal framework. Because of these interests, the market structure as well as the structure of EU competition law and patent law, various situations arise where so-called pay-for-delay agreements are pushing the framework to its limits. LÄS MER

7. 5. Pay-for-delay: A competition law analysis of settlement agreements in the pharmaceutical sector

   Uppsats för yrkesexamina på avancerad nivå, Stockholms universitet/Juridiska institutionen

   Författare :Christine-Jane Selenhag; [2019]
   Nyckelord :pay-for-delay; EU competition law; pharmaceutical sector; patent settlement agreements; patent law; article 101 TFEU; originator company; generic company;

   Sammanfattning : During the last two decades many pharmaceutical originator companies have struggled with refilling its pipelines with novel pharmaceutical products. At the same time many of these companies have lost patent protection for its most profitable drugs and more are expected to do so in the very near future. LÄS MER